Correlation Profile of Suppression of Tumorigenicity 2 and/or Interleukin-33 with Biomarkers in the Adipose Tissue of Individuals with Different Metabolic States.
Amal HasanShihab KochumonEbaa Al-OzairiJaakko TuomilehtoFahd Al-MullaRasheed AhmadPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2020)
Adipose tissue ST2 and IL-33 show different correlation profiles with various immunometabolic biomarkers depending on the metabolic state of the individuals. Therefore, targeting the IL-33/ST2 axis might form the basis for novel therapies to combat metabolic disorders.